BIKTARVY (DTP)
As part of a creative accelerator, I developed a detail aid for community liaisons (CLs) to educate patients and allied health professionals about all things BIKTARVY. The goal of the creative accelerator was to help streamline the usual process of asset creation and review in order to fast-track priority tactics, cutting down development time from months to weeks. Through strong collaboration with the team and client, we were able to complete this project in just two rounds of regulatory review.
TikTok is so hot right now. But what if you don’t have the budget for a whole new shoot? I’ve helped transform existing video assets into something that fits into short form, is approvable, and still tells a story that patients can find engaging.
A label update for BIKTARVY and updated guidance from the US Department of Health and Human Services (DHHS) suggests that women who are taking BIKTARVY and become pregnant can continue to take BIKTARVY. This update was an opportunity to speak more directly to women, an often overlooked demographic in HIV, about their treatment journey.
